A COMPARISON OF SOFOSBUVIR/VELPATASVIR AND GLECAPREVIR/PIBRENTASVIR FOR THE TREATMENT OF HEPATITIS C INFECTION AMONG PEOPLE WHO INJECT DRUGS

A comparison of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for the treatment of hepatitis C infection among people who inject drugs

Background: To eliminate hepatitis C (HCV) infection as a public health concern by 2030, there is a need to develop comprehensive programs among key populations such as people who use drugs (PWUD).Two highly effective regimens are available for initial therapy: glecaprevir/pibrentasvir (G/P) given as 3 tablets/day for 8 weeks and sofosbuvir/velpata

read more



Awake thoracic epidural anaesthesia for laparotomy: A safer alternative to general anaesthesia in asthmatic patients

Asthma is a common obstructive lung disease with a hallmark of airway inflammation and hyper-reactivity in response to a variety of stimuli.The morbidity and mortality in asthma is directly related to reversible airway obstruction and bronchospasm in response to specific triggers.The goal of the anaesthetist Tumbler is to avoid eliciting triggering

read more